Fig. 2
From: Effect of estrogen receptor β agonists on proliferation and gene expression of ovarian cancer cells
Effects of ERβ-agonists on growth of OVCAR-3 and OAW-42 ovarian cancer cells. OVCAR-3 and OAW-42 cells cultured in medium containing 10% FCS (open squares) or defined serum replacement SR2 (filled triangles) were treated with 10 nM of ERB-041, WAY-200070, Liquiritigenin or 3β-Adiol as indicated for up to 7 days and relative numbers of viable cells were determined by means of the fluorimetric CellTiter-Blue® Assay (Promega). Data are expressed in percent of the vehicle controls (n = 4; * P < 0.05 vs. control; ** P < 0.01 vs. control)